Search alternatives:
largest decrease » larger decrease (Expand Search), marked decrease (Expand Search)
latest decrease » greatest decrease (Expand Search), largest decreases (Expand Search), latency decreased (Expand Search)
small decrease » small increased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
largest decrease » larger decrease (Expand Search), marked decrease (Expand Search)
latest decrease » greatest decrease (Expand Search), largest decreases (Expand Search), latency decreased (Expand Search)
small decrease » small increased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
1
Table 1_Previous treatment decreases efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer.doc
Published 2025“…Background<p>Pralsetinib is a selective RET inhibitor. The ARROW trial revealed that RET fusion-positive non-small-cell lung cancer (NSCLC) can benefit from pralsetinib with tolerable adverse events (AEs). …”
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
Trends in the characteristics of women giving birth vaginally in France between 2010 and 2021.
Published 2025Subjects: -
12
-
13
-
14
-
15
Characteristics of the population studied.
Published 2024“…One of the negative perceptions identified in the study involves a misunderstanding of the association between PrEP users and the HIV/AIDS status. …”
-
16
Overview of the validated interview guide.
Published 2024“…One of the negative perceptions identified in the study involves a misunderstanding of the association between PrEP users and the HIV/AIDS status. …”
-
17
-
18
-
19
-
20